Skip to main content
Livermore
Livermore
ZHEN

TD Private Client Wealth LLC

SEC CIK
0001551017
Latest filing
Aug 4, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by TD Private Client Wealth LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
89
Value
$5.09K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of BMRN by TD Private Client Wealth LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202689$5.09K<0.1%+86+2,866.7%AddedHolders
Q1 20263$169<0.1%00.0%UnchangedHolders
Q4 20253$178<0.1%+3NewHolders
Q3 20250$00.0%−504−100.0%Sold outHolders
Q2 2025504$27.7K<0.1%−178−26.1%ReducedHolders
Q1 2025682$48.2K<0.1%+46+7.2%AddedHolders
Q4 2024636$41.8K<0.1%+126+24.7%AddedHolders
Q3 2024510$35.8K<0.1%+186+57.4%AddedHolders
Q2 2024324$26.7K<0.1%+75+30.1%AddedHolders
Q1 2024249$21.7K<0.1%+108+76.6%AddedHolders
Q4 2023141$13.6K<0.1%+24+20.5%AddedHolders
Q3 2023117$10.4K<0.1%+11+10.4%AddedHolders
Q2 2023106$9.19K<0.1%+26+32.5%AddedHolders
Q1 202380$7.78K<0.1%+14+21.2%AddedHolders
Q4 202266$6.83K<0.1%+10+17.9%AddedHolders
Q3 202256$4.75K<0.1%00.0%UnchangedHolders
Q2 202256$4.64K<0.1%00.0%UnchangedHolders
Q1 202256$4.32K<0.1%−14−20.0%ReducedHolders
Q4 202170$6.18K<0.1%+30+75.0%AddedHolders
Q3 202140$3.09K<0.1%−8−16.7%ReducedHolders
Q2 202148$4.00K<0.1%+11+29.7%AddedHolders
Q1 202137$2.79K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.